The anti-inflammatory effects of HTS and the fact that it has been well tolerated in CF patients makes it a potentially attractive therapeutic candidate in the treatment of ARDS/ALI in which several pro-inflammatory mediators such as IL-6 and IL-8 are elevated. This evidence concerns the gene IL6 and cystic fibrosis.